Sinocare Inc - Asset Resilience Ratio

Latest as of September 2025: 3.53%

Sinocare Inc (300298) has an Asset Resilience Ratio of 3.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 300298 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥220.56 Million
≈ $32.27 Million USD Cash + Short-term Investments

Total Assets

CN¥6.25 Billion
≈ $914.34 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2008–2024)

This chart shows how Sinocare Inc's Asset Resilience Ratio has changed over time. See 300298 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Sinocare Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300298 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥220.56 Million 3.53%
Total Liquid Assets CN¥220.56 Million 3.53%

Asset Resilience Insights

  • Limited Liquidity: Sinocare Inc maintains only 3.53% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Sinocare Inc Industry Peers by Asset Resilience Ratio

Compare Sinocare Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 39.15%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Dirui Industrial Co Ltd
SHE:300396
Medical Devices 6.89%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%

Annual Asset Resilience Ratio for Sinocare Inc (2008–2024)

The table below shows the annual Asset Resilience Ratio data for Sinocare Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 1.80% CN¥110.00 Million
≈ $16.10 Million
CN¥6.10 Billion
≈ $892.27 Million
+1.30pp
2023-12-31 0.51% CN¥30.00 Million
≈ $4.39 Million
CN¥5.93 Billion
≈ $867.30 Million
-0.22pp
2021-12-31 0.72% CN¥30.00 Million
≈ $4.39 Million
CN¥4.15 Billion
≈ $607.79 Million
-10.89pp
2017-12-31 11.61% CN¥193.11 Million
≈ $28.26 Million
CN¥1.66 Billion
≈ $243.32 Million
-0.66pp
2016-12-31 12.27% CN¥180.80 Million
≈ $26.46 Million
CN¥1.47 Billion
≈ $215.62 Million
-2.17pp
2015-12-31 14.44% CN¥192.66 Million
≈ $28.19 Million
CN¥1.33 Billion
≈ $195.21 Million
-1.25pp
2014-12-31 15.69% CN¥190.14 Million
≈ $27.82 Million
CN¥1.21 Billion
≈ $177.32 Million
+15.64pp
2009-12-31 0.06% CN¥39.42K
≈ $5.77K
CN¥71.26 Million
≈ $10.43 Million
+0.01pp
2008-12-31 0.04% CN¥12.94K
≈ $1.89K
CN¥29.34 Million
≈ $4.29 Million
--
pp = percentage points

About Sinocare Inc

SHE:300298 China Medical Devices
Market Cap
$1.19 Billion
CN¥8.11 Billion CNY
Market Cap Rank
#8334 Global
#2035 in China
Share Price
CN¥14.48
Change (1 day)
-1.16%
52-Week Range
CN¥14.48 - CN¥23.46
All Time High
CN¥47.34
About

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic disease… Read more